
Tri Glibegen 5mg/500mg/15mg Tablet
Marketer
Newgen Pharma
Salt Composition
Glibenclamide (5mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Tri Glibegen 5mg/500mg/15mg Tablet
Glibetril 5mg/500mg/15mg tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Administer Glibetril 5mg/500mg/15mg tablets with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic response. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to hyperglycemia and potentially serious complications including nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication forms part of a comprehensive diabetes management plan, encompassing dietary modifications, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent adverse effect. Learn to recognize its symptoms – sweating, dizziness, headache, tremors – and know how to treat it promptly. Maintaining regular meals and carrying a readily available fast-acting glucose source (e.g., sugary snacks or juice) is crucial for prevention. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, visual disturbances, fractures, and upper respiratory infections. Weight gain may occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of cardiovascular disease before commencing treatment; this medication may be unsuitable. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Primary Ingredients of Tri Glibegen 5mg/500mg/15mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Tri Glibegen 5mg/500mg/15mg Tablet
Managing Type 2 Diabetes
Major Benefits of Tri Glibegen 5mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Tri Glibegen 5mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Tri Glibegen 5mg/500mg/15mg Tablet:
- Anemia (low number of red blood cells)
- Hypoglycemia (low blood glucose level)
- Diarrhea
- Weight gain
- Headache
- Nausea
- Vomiting
- Blood in urine
- Erectile dysfunction
- Visual disorder
- Abdominal pain
How to use Tri Glibegen 5mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tri Glibegen 5mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How Tri Glibegen 5mg/500mg/15mg Tablet works:
Tri Glibegen 5mg/500mg/15mg tablets combine three distinct antidiabetic agents—glibenclamide, metformin, and pioglitazone—to enhance blood sugar management when single or dual medication proves insufficient. Glibenclamide, a sulfonylurea, stimulates pancreatic insulin release, thereby reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Tri Glibegen 5mg/500mg/15mg tablets with alcohol is not advised due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of Tri Glibegen 5mg/500mg/15mg tablets is contraindicated during pregnancy due to established risks to fetal development. In exceptional life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Medical advice is essential.
Breast feedingUNSAFE
Using Tri Glibegen 5mg/500mg/15mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingCONSULT YOUR DOCTOR
Driving ability while taking Tri Glibegen 5mg/500mg/15mg tablets is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyUNSAFE
Use of Tri Glibegen 5mg/500mg/15mg tablets is likely inadvisable for individuals with kidney impairment and should be omitted. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Tri Glibegen 5mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Tri Glibegen 5mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Tri Glibegen 5mg/500mg/15mg Tablet :
Should you forget a Tri Glibegen 5mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tri Glibegen 5mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
